GenePath Diagnostics
PrivateLast Round
Grant
Nov 23, 2020
Est. Valuation
$3.47M
Total Funding Raised
$2.19M
Company Overview
GenePath Diagnostics is a biotechnology company that develops and manufactures in vitro molecular diagnostic kits and provides clinical genomic testing services for infectious diseases, oncology, and genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenePath Diagnostics Comparables
Compare GenePath Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Huwel Lifesciences | 88% | |
| NeoDx Biotech Labs | 86% | |
| Genes2Me | 84% | |
GenePath Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 23, 2020 | ||||
| Seed | Feb 1, 2016 |
Key People
Founding team and executive leadership
GenePath Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saama Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 163% MoM.
- Jan 5, 2026
Monthly visitors increased 36% MoM.
GenePath Diagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GenePath Diagnostics's valuation, stock price, and market status.